ADC Therapeutics (ADCT)
Develops and sells ZYNLONTA while pursuing broader lymphoma use.
$1.32
Pre-market−0.01 (−0.38%)
At close$1.33(+7.29%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions122 holders · as of Mar 31, 2026 · largest filers plus last quarter's tail | ≈ 65.40% | 83.50M shares | |
| Insiders14 holders · as of Jul 2, 2026 | 12.28% | 15.68M shares | |
| Strategic holders2 holders · as of Feb 17, 2026 | 15.71% | 20.06M shares | |
| Otherremainder | ≈ 6.61% | 8.43M shares |
127.67M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
Institutions13F, as of Mar 31, 2026
122 holders · 83.50M shares · 19 new positions · 71 increased · 29 reduced · 16 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Redmile Group, LLC | 15.47M | 12.12% | −196.2K | May 15, 2026 |
| TCG Crossover Management, LLC | 11.39M | 8.92% | 0 | May 15, 2026 |
| Prosight Management, LP | 8.30M | 6.50% | −177.3K | May 15, 2026 |
| BlackRock, Inc. | 6.25M | 4.90% | +823.4K | May 13, 2026 |
| Eventide Asset Management, LLC | 5.70M | 4.47% | +2.34M | May 15, 2026 |
| Nantahala Capital Management, LLC | 5.60M | 4.38% | +122.0K | May 15, 2026 |
| Morgan Stanley | 3.81M | 2.99% | +42.8K | May 15, 2026 |
| Point72 Asset Management, L.P. | 3.38M | 2.65% | −1.63M | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Redmile Group, LLC | 9.90% | 12.72M | 13G | Apr 24, 2026 ↗ |
| Nantahala Capital Management, LLC | 9.69% | 12.33M | 13G | Aug 14, 2026 ↗ |
| TCG Crossover GP II, LLC | 9.20% | 11.39M | 13G | Feb 17, 2026 ↗ |
| HPWH TH AG | 8.52% | 8.67M | 13G | May 19, 2025 ↗ |
| Prosight Management, LP | 6.80% | 8.48M | 13G | Feb 13, 2026 ↗ |
| BlackRock, Inc. | 5.40% | 6.86M | 13G | Jul 27, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 2, 2026 | Redmile Group, LLC10 percent owner | Sale · 2 lots | 5,163,997 | $3.28 | 22,932,028 |
| Apr 1, 2026 | Redmile Group, LLC10 percent owner | Sale · 2 lots | 331,782 | $3.80 | 28,096,025 |
| Mar 31, 2026 | Redmile Group, LLC10 percent owner | Sale · 2 lots | 384,636 | $3.75 | 28,427,807 |
| Oct 27, 2025 | Redmile Group, LLC10 percent owner | Purchase | 3,846,153 | 3,846,153 |
CongressHouse and Senate disclosures
Not reported.